Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€461.00
17.04.23
€542.27
17.04.24
-2.12%
02:15

Royal Bank of Canada 
17.04.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€461.00
17.04.23
€577.08
17.04.24
-2.12%
02:15

Raymond James 
17.04.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€37.60
15.04.23
€40.00
15.04.24
-34.95%
16.04.24

Could be worthwhile Investment >10% per year
melinda 
15.04.23 20%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€103.40
11.04.23
€113.61
11.04.24
13.73%
12.04.24

Guggenheim 
11.04.23 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€103.80
11.04.23
€119.08
11.04.24
13.29%
12.04.24

Mizuho 
11.04.23 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€98.50
17.03.23
€122.19
17.03.24
12.89%
18.03.24

Mizuho 
17.03.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€435.50
11.03.23
-
11.03.24
2.76%
12.03.24

StockNews.com 
11.03.23 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€44.90
18.10.22
-
18.11.26
-44.54%
11.03.24

Probably not worthwhile Investment
Lutz69 
18.10.22 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€105.80
08.03.23
€120.43
08.03.24
6.62%
09.03.24

Atlantic Securities 
08.03.23 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€104.80
07.03.23
€122.89
07.03.24
8.21%
08.03.24

Mizuho 
07.03.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€449.75
04.03.23
-
04.03.24
-1.39%
05.03.24

StockNews.com 
04.03.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€450.10
28.02.23
€569.31
28.02.24
1.53%
29.02.24

Stephens 
28.02.23 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€153.36
24.01.23
€160.00
24.01.24
-4.60%
25.01.24

Could be worthwhile Investment >10% per year
melinda 
24.01.23 10%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
24.07.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
20.07.22 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€175.60
13.07.22
€168.00
13.07.23
-19.13%
13.07.23

francisco20 
13.07.22 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.70
22.05.23
€50.00
22.05.24
1.68%
08.06.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
22.05.23 70%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.95
22.05.23
€50.00
31.07.23
5.15%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
22.05.23 70%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.24
31.07.22
€50.00
31.07.23
-31.05%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
31.07.22 70%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

Prof 
17.05.22 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€90.50
24.08.22
€120.00
24.08.23
17.79%
08.05.23

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
24.08.22 70%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€100.60
08.11.22
€150.00
31.01.25
5.77%
05.05.23

Could be worthwhile Investment >10% per year
BiotechBee 
08.11.22 70%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€174.42
27.04.22
€190.00
27.04.23
-15.38%
27.04.23

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
tbackenh 
27.04.22 100%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.65
07.04.22
€56.00
07.04.23
-24.58%
08.04.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
tbackenh 
07.04.22 60%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€47.88
25.03.22
€64.00
25.03.23
-21.14%
27.03.23

Could be worthwhile Investment >10% per year
Einsiedler 
25.03.22 90%